These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Cryopreservation of human fetal liver hematopoietic stem/progenitor cells using sucrose as an additive to the cryoprotective medium. Petrenko YA; Jones DR; Petrenko AY Cryobiology; 2008 Dec; 57(3):195-200. PubMed ID: 18765238 [TBL] [Abstract][Full Text] [Related]
7. [Freezing of umbilical blood cells in mechanical freezers (-80 degrees C)]. Paczkowska E Ann Acad Med Stetin; 2002; 48():117-33. PubMed ID: 14601473 [TBL] [Abstract][Full Text] [Related]
8. Adoption of long-term cultures to evaluate the cryoprotective potential of trehalose for freezing hematopoietic stem cells. Scheinkönig C; Kappicht S; Kolb HJ; Schleuning M Bone Marrow Transplant; 2004 Sep; 34(6):531-6. PubMed ID: 15286692 [TBL] [Abstract][Full Text] [Related]
9. Cryopreservation with hydroxyethylstarch (HES) + dimethylsulfoxide (DMSO) gives better results than DMSO alone. Clapisson G; Salinas C; Malacher P; Michallet M; Philip I; Philip T Bull Cancer; 2004 Apr; 91(4):E97-102. PubMed ID: 15562559 [TBL] [Abstract][Full Text] [Related]
10. The viability of cryopreserved PBPC depends on the DMSO concentration and the concentration of nucleated cells in the graft. Liseth K; Abrahamsen JF; Bjørsvik S; Grøttebø K; Bruserud Ø Cytotherapy; 2005; 7(4):328-33. PubMed ID: 16162454 [TBL] [Abstract][Full Text] [Related]
11. Quantification of residual dimethylsulfoxide after washing cryopreserved stem cells and thawing tissue grafts. Decot V; Houzé P; Stoltz JF; Bensoussan D Biomed Mater Eng; 2009; 19(4-5):293-300. PubMed ID: 20042796 [TBL] [Abstract][Full Text] [Related]
12. Determining post-thaw CD34+ cell dose of cryopreserved haematopoietic progenitor cells demonstrates high recovery and confirms their integrity. Reich-Slotky R; Colovai AI; Semidei-Pomales M; Patel N; Cairo M; Jhang J; Schwartz J Vox Sang; 2008 May; 94(4):351-7. PubMed ID: 18179677 [TBL] [Abstract][Full Text] [Related]
13. Peripheral blood-derived stem cells can be successfully cryopreserved without using controlled-rate freezing. Jackson J; Kloster T; Welniak L; Damon M; Rehder B; Schmechel B; Ward B; Kessinger A Prog Clin Biol Res; 1992; 377():367-71. PubMed ID: 1279713 [No Abstract] [Full Text] [Related]
14. Collection strategies and cryopreservation of umbilical cord blood. Skoric D; Balint B; Petakov M; Sindjic M; Rodic P Transfus Med; 2007 Apr; 17(2):107-13. PubMed ID: 17430466 [TBL] [Abstract][Full Text] [Related]
15. Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing. Calmels B; Houzé P; Hengesse JC; Ducrot T; Malenfant C; Chabannon C Bone Marrow Transplant; 2003 May; 31(9):823-8. PubMed ID: 12732892 [TBL] [Abstract][Full Text] [Related]
16. Autologous stem cell transplantation with stem cells preserved in the presence of 4.5 and 2.2% DMSO. Lakota J; Fuchsberger P Bone Marrow Transplant; 1996 Jul; 18(1):262-3. PubMed ID: 8832035 [No Abstract] [Full Text] [Related]
17. Better preservation of early hematopoietic progenitor cells when human peripheral blood progenitor cells are cryopreserved with 5 percent dimethylsulfoxide instead of 10 percent dimethylsulfoxide. Abrahamsen JF; Rusten L; Bakken AM; Bruserud Ø Transfusion; 2004 May; 44(5):785-9. PubMed ID: 15104663 [TBL] [Abstract][Full Text] [Related]
18. Analysis of variations in cryomedium and methods of freezing on human bone marrow stem cells. O'Kane-Murphy B; Jackson JD; Dicke KA Prog Clin Biol Res; 1992; 377():361-6. PubMed ID: 1438432 [No Abstract] [Full Text] [Related]
19. Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres. Windrum P; Morris TC; Drake MB; Niederwieser D; Ruutu T; Bone Marrow Transplant; 2005 Oct; 36(7):601-3. PubMed ID: 16044141 [TBL] [Abstract][Full Text] [Related]